Literature DB >> 25327089

Echocardiographic assessment of cardiac dysfunction in patients of end stage renal disease on haemodialysis.

Mukesh Laddha, Vishal Sachdeva, P M Diggikar, P K Satpathy, A L Kakrani.   

Abstract

OBJECTIVE: To assess the prevalence of systolic and diastolic dysfunction in patients of end stage renal disease (ESRD) on haemodialysis.
METHODS: Seventy patients with ESRD were subjected to two-dimensional and M mode echocardiography for determination of systolic and diastolic dysfunction. All patients were evaluated clinically, biochemically and radiologically and were diagnosed as chronic kidney disease (CKD). The left ventricular ejection fraction (LVEF) and fractional shortening (FS) were taken as measures of left ventricular (LV) systolic function. Diastolic function was determined by measuring E/A ratio by spectral doppler LV inflow velocity. Echocardiographic findings of hypertensive and normotensive patients were compared.
RESULTS: Out of 70 patients studied, there were 53 males (75.7%) and 17 females (24.3%). Hypertension (37.1%) was leading cause of ESRD. Echocardiography showed that left ventricular hypertrophy (LVH) was present in 74.3%. Systolic dysfunction as measured by reduced fractional shortening (<25%) and decreased LVEF (< 50%) was present in 8.6% and 24.3% respectively. Diastolic dysfunction as denoted by E/A ratio of less than 0.75 or more than 1.8 was present in 61.4% of patients. Regional wall motion abnormality (RWMA) was present in 12.9%. Pericardial effusion was noted in 14.3% of patients. Valvular calcification was noted in 7.1% of ESRD patients. Mean left ventricular internal diameter in diastole was 45.55 +/- 6.03 mm. Mean Interventricular septum diameters in systole was 12.2 +/- 1.71 mm. Mean left atrium diameter was 33.01 +/- 4.11 mm. Normotensive group was compared to hypertensive group. Statistically significant difference was noted in LVH and E/A ratio in hypertensive group as compared to normotensive group.
CONCLUSION: Patients with hypertensive ESRD had higher prevalence of diastolic and systolic dysfunction as compared to normotensive counterparts.

Entities:  

Mesh:

Year:  2014        PMID: 25327089

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  6 in total

Review 1.  Cardiac Ultrasound for the Nephrologist: Know Thy Heart to Know Thy Kidneys.

Authors:  Pankaj Goyal; Joseph Minardi; Ankit Sakhuja
Journal:  Adv Chronic Kidney Dis       Date:  2021-05       Impact factor: 3.620

2.  Automated Determination of Left Ventricular Function Using Electrocardiogram Data in Patients on Maintenance Hemodialysis.

Authors:  Akhil Vaid; Joy J Jiang; Ashwin Sawant; Karandeep Singh; Patricia Kovatch; Alexander W Charney; David M Charytan; Jasmin Divers; Benjamin S Glicksberg; Lili Chan; Girish N Nadkarni
Journal:  Clin J Am Soc Nephrol       Date:  2022-06-06       Impact factor: 10.614

3.  Early predictors of cardiac dysfunction in Egyptian children with chronic kidney disease.

Authors:  Mohamed Abdelaziz El-Gamasy; Walid Ahmed El-Shehaby; Maaly M Mabrouk
Journal:  Ann Pediatr Cardiol       Date:  2019 Jan-Apr

4.  Impact of Oxidative Stress in Premature Aging and Iron Overload in Hemodialysis Patients.

Authors:  Blanca Murillo-Ortiz; Joel Ramírez Emiliano; Wendy Ivett Hernández Vázquez; Sandra Martínez-Garza; Sergio Solorio-Meza; Froylán Albarrán-Tamayo; Edna Ramos-Rodríguez; Luis Benítez-Bribiesca
Journal:  Oxid Med Cell Longev       Date:  2016-10-05       Impact factor: 6.543

5.  Gender-specific association of decreased estimated glomerular filtration rate and left vertical geometry in the general population from rural Northeast China.

Authors:  Dongxue Dai; Ye Chang; Yintao Chen; Shasha Yu; Xiaofan Guo; Yingxian Sun
Journal:  BMC Cardiovasc Disord       Date:  2017-01-13       Impact factor: 2.298

6.  Predisposing factors and uremic pericardial effusion among ESRD patients undergoing dialysis.

Authors:  Ziba Aghsaeifard; Rahim Firouzi; Reza Alizadeh
Journal:  Ann Med Surg (Lond)       Date:  2022-04-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.